SCHEMBL8807986

SCHEMBL8807986

COc1ccc(CCN(C)CCOc2ccc(NC(=O)c3cccc4c(=O)c5cc(F)ccc5sc34)cc2)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.41
▸ KDR P35968 3/20 0.41
▸ MAPK1 P28482 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ ABCG2 Q9UNQ0 3/20 0.39
▸ ABCB1 P08183 2/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TP53 P04637 3/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8807068 0.92 KCNH2 (0.44) KCNH2KDRMAPK1LMNADRD2
SCHEMBL8806058 0.90 ABCB1 (0.43) MAPK1LMNAABCG2ABCB1KDM4E
SCHEMBL8806933 0.89 KDM4E (0.42) MAPK1LMNAABCG2ABCB1KDM4E
SCHEMBL8808236 0.88 MAPT (0.45) KCNH2KDRLMNAABCG2ABCB1
SCHEMBL8810117 0.85 MCHR1 (0.45) KDRMAPK1DRD2DRD3HRH3
SCHEMBL8808386 0.85 MAPT (0.45) LMNAABCG2ABCB1KDM4EALDH1A1
SCHEMBL8807343 0.85 ABCB1 (0.42) MAPK1ABCG2ABCB1KDM4EALDH1A1
SCHEMBL8806941 0.85 ABCG2 (0.40) MAPK1LMNAABCG2ABCB1MAOB
SCHEMBL8806985 0.84 ABCB1 (0.42) MAPK1ABCG2ABCB1TP53RXFP1
SCHEMBL8807995 0.84 MAOA (0.39) KCNH2KDRMAPK1DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback